The period following completion of an i nitial TMS course is critical . At Inspire TMS Denver , we think of the first 90 days as the window when early gains are consolidated, problems are caught early, and long-term plans (maintenance or boosters) are agreed upon. This practical roadmap explains what clinicians monitor, when a booster or maintenance plan is recommended, and what patients can do to protect and extend benefit. Why the first 90 days matter TMS causes brain-level changes that unfold over weeks . Some people improve quickly and continue to get better; others show delayed responses or need a small clinical adjustment to translate early signals into durable benefit. The first 90 days are when clinicians can: Detect early response vs plateau Make targeted adjustments (remap, pacing, or protocol change) Decide whether boosters or a maintenance schedule will help sustain gains. A proactive, measured approach during this window reduces the chance that patients drift away from care when benefit is still within reach. What clinicians routinely measure and why At Inspire, we rely on objective signals plus clinical judgment. The core things we track are: 1. Standard outcome scores (weekly → monthly) PHQ-9 for depression , GAD-7 for anxiety , and other condition-specific scales. These reveal numeric trends that often precede clear subjective change. We typically collect baseline scores, then repeat them weekly (early weeks), moving to biweekly/monthly checks as things stabilize. 2. Functional markers Sleep, work/school performance, social engagement, and daily activities are measured via short checklists. Function often improves alongside symptom scores - sometimes even earlier. 3. Safety & tolerability Headache, scalp discomfort, fatigue, and any neuro symptoms. Persistent or new neurological issues trigger urgent review. 4. Medication, sleep, and life events Changes in meds, poor sleep, or acute stress/medical events strongly affect response and are always reviewed. 5. Treatment adherence & session data Missed sessions, pacing changes, or protocol deviations are tracked because they affect outcomes.

If you live in Boulder or the nearby Front Range and are considering TMS , Inspire TMS Denver in Broomfield is an easy, physician-led option for local care and short-trip accelerated plans. Below you’ll find practical local details - approximate drive times, One-Day logistics, hotel & travel tips, and how to get a no-surprise, itemized estimate for your visit. Why Boulder residents come to Inspire TMS Denver Physician-led care: Dr. Samuel Clinch personally oversees mapping and accelerated One-Day courses. Precision mapping: We perform motor-threshold mapping before any accelerated plan so dose and coil position are individualized. One-Day capability: For patients who need fast delivery of the full course, we offer physician-supervised One-Day (20 sessions in 1–2 days) and other accelerated protocols. Outcome tracking & follow-up: We monitor PHQ-9/GAD-7 scores and make data-driven adjustments (remap, pacing, boosters) so your trip produces measurable results.

Mapping is the clinical step that makes TMS precise. At Inspire TMS Denver, we use motor-threshold mapping to find the coil position and stimulation intensity that reliably affect the brain area we intend to treat. But mapping is not a one-and-done ritual - sometimes a fresh map is the right next step. Remapping is a normal, evidence-based part of precision care: it helps the team fine-tune treatment so sessions are safer, more reproducible, and more likely to work. Below is a clear explanation of why we remap, the remapping process, what patients experience, and real examples of how small changes can produce meaningful clinical gains. Why remap? The clinical reasons We commonly consider remapping after a careful review when any of the following apply: Early plateau or slow progress. If outcome scores (PHQ-9, GAD-7, or other scales) stop improving by the expected window (often around week 3), remapping helps determine whether coil position or intensity is limiting response. Prior TMS elsewhere. If you had TMS with a different device or clinic, anatomical and equipment differences can mean that a new, clinic-specific map improves reproducibility. Medication or medical changes. New medications, dose changes, or medical events that affect cortical excitability can change how your brain responds to stimulation. Change of protocol. Moving from standard rTMS to an accelerated plan, One-Day course, or iTBS may warrant a fresh map to ensure safe and effective dosing. Persistent discomfort or side effects. If you have repeated intolerable scalp discomfort or side effects that suggest coil angle/placement could be optimized, remapping is a logical fix. Equipment or technician change. Different coils or small technique differences can alter the effective stimulation; remapping restores precision. Importantly: remapping is not an admission of failure . It’s a targeted diagnostic step - think of it like recalibrating a medical device to match your brain’s current physiology. What happens during a remap? Comfort: You may feel brief tapping and small muscle twitches during mapping; discomfort is usually minimal. Adjustment period: If we change your dose or target, we monitor closely for comfort and early response. Timeline to effect: A beneficial remap sometimes produces earlier improvement in the following weeks, but improvements still unfold over days to weeks. Documentation: You’ll receive an updated map summary that you can share with other providers.

If you completed a One-Day (single-day) TMS course at Inspire - roughly 20 short sessions delivered in one (or two) tightly scheduled days - you’ve taken a fast, physician-supervised step toward change. This week-by-week roadmap explains typical recovery, the symptom signals we watch for, and exactly when to contact the clinic so you get the support you need. Quick reminder - What Happened That Day Your One-Day visit began with a physician consult and motor-threshold mapping , so dose and coil position were tailored to your brain. The day was paced with comfort breaks and outcome checks; you left with an end-of-day summary and follow-up plan. That mapping and documentation allow us to make data-driven decisions after you go home. Week 0 - The Day of Treatment (Immediate Recovery) Expect: Mild scalp soreness or tapping at the coil site, possible brief headache or fatigue by evening. Tips: Rest as needed, hydrate, and eat a normal meal. Avoid alcohol for 24 hours. Arrange a ride home if you feel tired. Call if: Severe symptoms (worsening headache, confusion, fainting). Week 1 - First Signals Expect: Some people notice early changes in sleep, anxiety, or mood; others notice little yet - both are normal. Mild side effects usually resolve. Clinic check: We compare your Week 1 outcome score to your baseline to assess early improvement. Call if: Side effects persist or you feel markedly worse. Read About: Pros & Cons Week 2 - Emerging Pattern Expect: Many patients begin to report clearer improvements (more energy, better sleep, less worry); responses vary. Clinic check: We repeat measures (e.g., PHQ-9) and review meds or sleep if improvement is limited. Call if: You’re concerned you’re not improving, or side effects interfere with daily life.

Patients tell us the same thing again and again in reviews: they want clear evidence that treatment is working. At Inspire TMS Denver, we take that request literally - we don’t rely on impressions alone. We measure, record, and act on standardized outcome scores (like the PHQ-9) so every treatment decision is informed by data. That’s why our clinic reviews - the patient stories and high ratings you see online - are paired with hard numbers in our records: we translate “I feel better” into measurable change, and we use those numbers to shape treatment, follow-up, and long-term care. Why measurement matters TMS is powerful because it changes brain circuits. But brain change doesn’t always track neatly with how someone says they feel, especially early in treatment. Standardized scales give clinicians a consistent, sensitive way to detect meaningful clinical change, monitor safety, and decide whether to continue, adjust, or remap a course. At Inspire, we routinely use validated tools ( most commonly the PHQ-9 for depression, and condition-specific measures where appropriate ) before treatment, during the course, and at follow-up. These measures let us answer the crucial questions: Is the patient improving, and by how much? Is the current protocol producing the expected signal? Do we need to remap, change pacing, or offer a maintenance/rescue plan? Collecting and reviewing scores is not paperwork - it is how we turn patient experience into reproducible clinical decisions. What your scores actually mean (PHQ-9 primer) A few PHQ-9 facts are useful for patients: PHQ-9 range: 0–27. Lower is better. Common interpretive bands: 0–4 (minimal), 5–9 (mild), 10–14 (moderate), 15–19 (moderately severe), 20–27 (severe). Clinical response is often defined as a ≥50% reduction in PHQ-9 score from baseline; remission is typically a score in the minimal or near-minimal range. These guidelines let clinicians quantify improvement and compare progress across visits. Research and clinic reports commonly show robust response and remission rates when TMS is delivered to completion - published and clinic-level data often cite response rates in the 60–75% range and remission rates approaching ~45–51% among full-course completers. Those benchmarks help us set realistic expectations and evaluate our own results. How Inspire uses scores day-to-day Here’s how outcome tracking informs care at Inspire: Baseline & goals. We collect a baseline PHQ-9 (and other relevant scales). Dr. Clinch and the team set realistic targets and timelines — e.g., a 50% score reduction by week 4–6 — and share those with the patient. Frequent measurement. We repeat scores at scheduled intervals during treatment (weekly or at clinically meaningful points) so we can detect early signals that predict longer-term response. Data-driven adjustments. If scores plateau or worsen, we don’t guess - we review: does mapping need refinement? Is a medication interaction or a sleep problem present? Should we change protocol pacing, remap, or consider a rescue/maintenance plan? Remapping or protocol changes are common, evidence-driven steps when the data suggest they’re needed. Shared results & transparency. We show patients their numbers over time so they can see the progress (or lack of it) and participate in decisions. This transparency is part of why many patients report a better experience at Inspire - they understand how clinical choices are made and why. Outcome scores and patient reviews - how they match up Patient reviews are invaluable : they capture nuance, meaning, and quality of experience. But reviews are subjective and influenced by many non-clinical factors (appointment flow, staff warmth, travel ease). Outcome tracking gives a reproducible, objective counterpart. At Inspire, we regularly compare patient-reported outcomes with review themes. When a patient posts a high-rating review that mentions life improvements, we can show the corresponding PHQ-9 change in the record. Conversely, when review feedback suggests a problem (e.g., persistent symptoms or side effects), our scores often highlight the clinical trajectory that underlies that feedback. This two-way verification - reviews and scores - helps us continuously improve care and confirms that good experience usually follows measurable clinical benefit.